2000
DOI: 10.1016/s0304-3835(00)00612-1
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of phospholipase D1 in human breast cancer tissues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
146
2

Year Published

2003
2003
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 187 publications
(155 citation statements)
references
References 30 publications
7
146
2
Order By: Relevance
“…61 Phospholipase D overexpression has been reported for many cancer types including breast cancer cell lines and tissue samples, as well as renal and gastric cancers and is associated with mTOR-mediated pro-survival phenotypes. [62][63][64][65] Thus, modification of the intracellular phospholipid code by changes in the expression and/or activity of various phospholipid modifiers can ultimately regulate tumor progression.…”
Section: Alteration Of the Phospholipid Code During Tumor Progressionmentioning
confidence: 99%
“…61 Phospholipase D overexpression has been reported for many cancer types including breast cancer cell lines and tissue samples, as well as renal and gastric cancers and is associated with mTOR-mediated pro-survival phenotypes. [62][63][64][65] Thus, modification of the intracellular phospholipid code by changes in the expression and/or activity of various phospholipid modifiers can ultimately regulate tumor progression.…”
Section: Alteration Of the Phospholipid Code During Tumor Progressionmentioning
confidence: 99%
“…PLD activity and expression has been reported to be elevated in a majority of breast (Noh et al, 2000) and renal (Zhao et al, 2000) cancers that were examined. MDA-MB-231 breast cancer cells have very highly elevated levels of PLD activity relative to other breast cancer cells, and PLD activity was implicated in the survival of this breast cancer cell line subjected to apoptotic stress (Zhong et al, 2003).…”
Section: Introductionmentioning
confidence: 99%
“…Our results argue that Prdx1 has a direct role in tumour suppression in older mice by eliminating ROS and preventing oxidative DNA damage. Prdx1 and other peroxiredoxins are overexpressed in some human cancers 25 , suggesting that tumours that arise through other mechanisms may benefit from increased amounts of peroxiredoxins. Our findings further suggest that Prdx1 regulates NK cell development and cytotoxic function through both cell-autonomous and cell-nonautonomous mechanisms, and that defective NK cell activity may predispose Prdx1 mutant mice to cancer through a loss of tumour surveillance.…”
mentioning
confidence: 99%